Description
Cartalax (LAX) is a peptide preparation for articular cartilage repair and soft tissue regeneration, suitable for cartilage wear and inflammation caused by sports injuries or degenerative diseases.
Effects
Promotes chondrocyte proliferation and matrix synthesis; inhibits the release of inflammatory factors in the joint cavity; accelerates the repair of ligaments, tendons and other soft tissues; reduces joint pain and stiffness; improves joint mobility and functional recovery; delays the progression of joint degenerative diseases.
Usage
2-3 times per week, 20mg (1 vial) each time, dissolved in saline for intramuscular or intra-articular injection. A course of 4-6 weeks is recommended. Adjust dosage and course according to physician's instructions.
Suitable for
Patients with articular cartilage wear or injury; sports enthusiasts and athletes; patients with early-stage osteoarthritis; those in need of soft tissue repair.
Not suitable for
Those allergic to any ingredient of Cartalax; individuals with severe liver or kidney dysfunction; those with active bleeding or coagulation disorders; pregnant women, nursing mothers, and minors under 16 years of age.
Ingredients
Cartalax (a synthetic peptide compound, molecular weight approximately 2000 Da), mannitol, phosphate buffer.
Storage
Store in a cool, dry place protected from light, sealed, at 2-8°C (refrigerated). Do not freeze.
Shelf life
24 months
